Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 30, 2000 - Issue 7
Submit an article Journal homepage
317
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Comparison of celecoxib metabolism and excretion in mouse, rabbit, dog, cynomolgus monkey and rhesus monkey

S. K. Paulson Pharmacokinetics, Bioanalytical & Radiochemistry
,
J. Y. Zhang Regulatory Affairs
,
S. M. Jessen Physical Methodology, G. D. Searle & Co., 4901 Searle Parkway, Skokie, IL, USA
,
Y. Lawal Metabolic Chemistry, Covance Laboratories, Inc., Madison, WI, USA
,
N. W. K. Liu Pharmacokinetics, Bioanalytical & Radiochemistry
,
C. M. Dudkowski Regulatory Affairs
,
Y.-F. Wang Physical Methodology, G. D. Searle & Co., 4901 Searle Parkway, Skokie, IL, USA
,
M. Chang Metabolic Chemistry, Covance Laboratories, Inc., Madison, WI, USA
,
D. Yang Pharmacokinetics, Bioanalytical & Radiochemistry
,
J. W. A. Findlay Regulatory Affairs
,
M. A. Berge Physical Methodology, G. D. Searle & Co., 4901 Searle Parkway, Skokie, IL, USA
,
C. S. Markos Metabolic Chemistry, Covance Laboratories, Inc., Madison, WI, USA
,
A. P. Breau Pharmacokinetics, Bioanalytical & Radiochemistry
,
J. D. Hribar Regulatory Affairs
&
J. Yuan Physical Methodology, G. D. Searle & Co., 4901 Searle Parkway, Skokie, IL, USA
 show all
Pages 731-744 | Published online: 22 Sep 2008

References

  • CROFFORD, L. J., WILDER, R. L., RISTIMAKI, A. P., SANO, H., REMMERS, E. F., Epps, H. R. and HLA, T., 1994, Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues: effects of interleukin-1fl, phorbol ester, and corticosteroids. journal Clinical Investigation, 93, 1095–1101.
  • ISAKSON, P., ZWEIFEL, B., MASFERRER, J., KOBOLDT, C., SEIBERT,. K, HUBBARD, R., GEIS, S. and NEEDLEMAN, P. 1998, Specific COX-2 inhibitors: from bench to bedside. In J. Vane and J. Botting (eds), Selective COX-2 Inhibitors: Pharmacology, Clinical Effects and Therapeuth Potential (London: Kluwer and William Harvery), 127–133.
  • O'NEILL, G. P. and FORD-HUTCHINSON, A. W., 1993, Expression of messenger mRNA for cyclo-oxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Letters, 330, 156–1 60.
  • PAULSON, S. K., ENGEL, L., REITZ, B., BOLTEN, S., BURTON, E. G., MAZIASZ, T. J., YAN, B. and SCHOENHARD, G. L., 1999, Evidence for polymorphism in the canine metabolism of the cyclooxygenase 2 inhibitor, celecoxib. Drug Metabolism Disposition, 27, 1133–1142.
  • PAULSON, S. K., HRIBAR, J. D., Liu, N. W. K., HAJDu, E., BIBLE, R. H., P
  • IERGIES, A. and KARIM, A., 2000a, Metabolism and excretion of ["C] celecoxib in healthy male volunteers. Drug Metabolism Disposition, 28, 308–314.
  • PAULSON, S. K., ZHANG, J., BREAU, A. P., HRIBAR, J. D., Liu, N. W. K., JESSEN, S. M., LAWAL, Y. M., COGBURN, J. N., GRESK, C. J., MARKOS, C. S., SCHOENHARD, G. L. and BURTON, E. G., 2000b, Pharmacokinetics, tissue distribution, metabolism and excretion of celecoxib in rats. Drug Metabolism and Dispositicn, 28, 514–521.
  • PENNING, T. D., TALLEY, J. J., BERTENSHAW, S. R., CARTER, J. D., COLLINS, P. W., DOCTER, S., GRANETO, M. J., LEE, L. F., MALECHA, J. W., MIYASHIRO, J. M., ROGERS, R. S., ROGIER, D. J., Yu, S. S., ANDERSON, G. D., BURTON, E. G., COGBURN, J. N., GREGORY, S. A., KOBOLDT, C. M., PERKINS, W. E., SEIBERT, K., VEENHUIZEN, A. W., ZHANG, Y. Y. and ISAKSON, P. C., 1997, Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylpheny1)-3-(triluoromethyl)-1H-pyrazol-1-yl]bezenesulfonamich (SC-58635, celecoxib). Journal Medical Chemistry, 40, 1347–1365.
  • SEIBERT, K., ZHANG, Y., LEAHY, K., HAUSER, S., MASFERRER, J., PERKINS, W., LEE, L. and ISAKSON, P. C., 1994, Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proceedings of the National Academy of Sciences, USA, 91, 12013–12017.
  • SIDELMANN, U. G., LENZ, E. M., SPRAUL, M., HOFMANN, M., TROKE, J., SANDERSON, P. N., LINDON, J. C., WILSON, A. D. and NICHOLSON, J. K., 1996, 750 MHz HPLC-NMR spectroscopic studies on the separation and characterisation of the positional isomers of the glucuronides of 6,11-dihydro-11-oxodibenz [b,e] oxepin-2-acetic acid. Analytical Chemistry, 68, 106–110.
  • SIMON, L. S., LANZA, F. L., LIPSKY, P. E., HUBBARD, R. C., TALWALKER, S., SCHWARTZ, B. D., ISAKSON, P. C. and GEIS, G. S., 1998, Preliminary study of the safety and efficacy of SC-5 8635, a novel cyclooxygenase 2 inhibitor, Arthritis Rheumatology, 41, 1591–1602.
  • SPAHN-LANGGUTH, H. and BENET, L., 1992, Acyl glucuronides revisited: IS the glucuronidation process a toxification as well as a detoxification mechanism? Drug Metabolism Reviews, 241, 5–48.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.